Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24054375 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Smaranda Maier und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ist Neurology Clinic, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania. Hauptthemen laut MEDLINE: Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy, Science and Technology George Emil Palade Targu Mures, University of Medicine and Pharmacy, Science and Technology GE Palade Targu Mures.
Abstract (Originalsprache)
Despite extensive research into the pathophysiology of multiple sclerosis (MS) and recent developments in potent disease-modifying therapies (DMTs), two-thirds of relapsing-remitting MS patients transition to progressive MS (PMS). The main pathogenic mechanism in PMS is represented not by inflammation but by neurodegeneration, which leads to irreversible neurological disability. For this reason, this transition represents a critical factor for the long-term prognosis. Currently, the diagnosis of PMS can only be established retrospectively based on the progressive worsening of the disability over a period of at least 6 months. In some cases, the diagnosis of PMS is delayed for up to 3 years. With the approval of highly effective DMTs, some with proven effects on neurodegeneration, there is an urgent need for reliable biomarkers to identify this transition phase early and to select patients at a high risk of conversion to PMS. The purpose of this review is to discuss the progress made in the last decade in an attempt to find such a biomarker in the molecular field (serum and cerebrospinal fluid) between the magnetic resonance imaging parameters and optical coherence tomography measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ist Neurology Clinic, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania.
- Department of Neurology, 'George Emil Palade' University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540136 Targu Mures, Romania.
- Doctoral School, 'George Emil Palade' University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
- Center for Advanced Medical and Pharmaceutical Research, 'George Emil Palade' University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540136 Targu Mures, Romania.
ORCID-Profile: Smaranda Maier, Laura Barcutean, Sebastian Andone, Doina Manu
Förderung
- University of Medicine and Pharmacy, Science and Technology George Emil Palade Targu Mures
- University of Medicine and Pharmacy, Science and Technology GE Palade Targu Mures
Zitieren
APA
Maier, S., Barcutean, L., Andone, S., Manu, D., Sarmasan, E., Bajko, Z., & Balasa, R. (2023). Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054375
Vancouver
Maier S, Barcutean L, Andone S, Manu D, Sarmasan E, Bajko Z, et al. Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054375
BibTeX
@article{Maier2023,
author = {Maier, Smaranda and Barcutean, Laura and Andone, Sebastian and Manu, Doina and Sarmasan, Emanuela and Bajko, Zoltan and Balasa, Rodica},
title = {Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24054375}
}
EUVIMED